98%
921
2 minutes
20
Biosensor-based, real-time stress detection has generated clinical interest for the purpose of driving just-in-time interventions that support recovery from mental disorders. Most stress detection models to date, however, have been trained with laboratory-based data from homogenous samples of healthy adults, and do not perform as well in clinical populations. As an initial step toward the development of a stress detection algorithm that functions well in clinical populations, we tested a series of stress-detection machine learning models on ambulatory electrocardiogram (ECG) and daily ecological momentary assessment (EMA) data collected from a sample of individuals in early recovery from alcohol use disorder (AUD). Forty-four individuals ages 18-65 in the first year of a current AUD recovery attempt wore an ECG monitor for 4 days, while concurrently completing 3-times-daily EMA of stress. Data were segmented and normalized. Target features were identified using unsupervised learning models (e.g., t-SNE, cluster analysis) and supervised learning models were tuned to optimize model performance. As a comparator, we also tested these models with laboratory-derived stress data from a sample of healthy young adults. Before accounting for individual characteristics, we achieved a modest accuracy of 63% in our clinical sample, which compared to 94% accuracy in the laboratory-derived healthy young adult sample. After accounting for age and body-mass-index (BMI) we increased model accuracy up to 80% in our clinical sample. Stress detection is challenging in clinical populations; however, better prediction is possible with data normalization and stratification considering age and BMI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10484-025-09714-0 | DOI Listing |
Nat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDFAnaesthesiologie
September 2025
Klinik für Anästhesiologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Sodium-glucose Cotransporter 2 (SGLT-2) inhibitors are oral antidiabetic drugs that were developed for the treatment of patients with diabetes mellitus and are now also approved for treating chronic heart failure and chronic kidney disease. By inhibiting SGLT‑2 in the proximal renal tubule, urinary excretion of glucose is increased. Large randomized trials have demonstrated improved glycemic control, reduced cardiovascular events and lower mortality but also an increased risk of urogenital infections and dehydration.
View Article and Find Full Text PDFBioresour Technol
September 2025
College of Light Industry and Food Engineering, Guangxi University, Nanning 530004, People's Republic of China; Key Laboratory of Deep Processing and Safety Control for Specialty Agricultural Products in Guangxi Universities, Education Department of Guangxi Zhuang Autonomous Region, Nanning 530004,
This study investigated the inhibitory effect of sucrose on the autolysis of recombinant Bacillus subtilis WB600 during keratinase production and elucidated its mechanism. Growth curves, cell morphology observations, cell wall integrity detection, and transcriptome analysis revealed that 2 % sucrose significantly increased cell biomass and delayed autolysis. Keratinase activity reached 5670.
View Article and Find Full Text PDFJ Ethnopharmacol
September 2025
Institute of Materia Medica, Jinzhou Medical University, Jinzhou, Liaoning 121001, China. Electronic address:
Ethnopharmacology Relevance: Tangningtongluo Tablets (TNTL), a novel Miao ethnic medicine for treating type 2 diabetes mellitus (T2DM) and its complications. However, its potential bioactive components and the pharmacological mechanisms underlying its therapeutic effects remain unclear.
Aim Of The Study: This study aims to preliminarily explore the protective effects of TNTL and its active components on pancreatic cells via the PI3K/Akt/FoxO1 pathway and further investigate the underlying mechanisms.
Clin Chim Acta
September 2025
Department of Physiology, University of Louisville, Louisville 40202 KY, USA. Electronic address:
Diabetic nephropathy (DN) is a major cause of end-stage renal disease, with podocyte injury representing an early pathogenic event. Conventional biomarkers such as albuminuria and eGFR identify renal damage only at advanced stages, limiting opportunities for timely intervention. Wilms' Tumor 1 (WT1), a podocyte-specific transcription factor, has emerged as a sensitive marker of early glomerular stress.
View Article and Find Full Text PDF